Literature DB >> 34850062

Cancer Microbiology.

Daniel DiMaio1,2,3,4, Brinda Emu4,5, Andrew L Goodman4,6, Walther Mothes4,6, Amy Justice4,7.   

Abstract

Microbes play important roles in cancer from direct carcinogenic effects to their use in treatment. Cancers caused by microorganisms account for approximately 15% of cancers, primarily in low- and middle-income countries. Unique features of infectious carcinogens include their transmissibility, mutability, and specific immune interactions, which provide challenges and opportunities for cancer prevention and treatment. For these agents, infection control through exposure reduction, antivirals, antibiotics, and vaccines is cancer control. In addition, developing evidence suggests that microorganisms including the human microbiome can indirectly modulate cancer formation and influence the effectiveness and toxicity of cancer treatments. Finally, microorganisms themselves can be used to prevent or treat cancer. The convergence of these factors signals the emergence of a new field, cancer microbiology. Recognition of cancer microbiology will spur research, stimulate cross-disciplinary training, inform drug development, and improve public health.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34850062      PMCID: PMC9086797          DOI: 10.1093/jnci/djab212

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   11.816


  158 in total

1.  A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein.

Authors:  M Lara-Tejero; J E Galán
Journal:  Science       Date:  2000-10-13       Impact factor: 47.728

2.  Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.

Authors:  Chi Ma; Miaojun Han; Bernd Heinrich; Qiong Fu; Qianfei Zhang; Milan Sandhu; David Agdashian; Masaki Terabe; Jay A Berzofsky; Valerie Fako; Thomas Ritz; Thomas Longerich; Casey M Theriot; John A McCulloch; Soumen Roy; Wuxing Yuan; Vishal Thovarai; Shurjo K Sen; Mathuros Ruchirawat; Firouzeh Korangy; Xin Wei Wang; Giorgio Trinchieri; Tim F Greten
Journal:  Science       Date:  2018-05-25       Impact factor: 47.728

3.  Conservation and Innovation of APOBEC3A Restriction Functions during Primate Evolution.

Authors:  Richard N McLaughlin; Jacob T Gable; Cristina J Wittkopp; Michael Emerman; Harmit S Malik
Journal:  Mol Biol Evol       Date:  2016-04-06       Impact factor: 16.240

4.  Global burden of cancers attributable to infections in 2012: a synthetic analysis.

Authors:  Martyn Plummer; Catherine de Martel; Jerome Vignat; Jacques Ferlay; Freddie Bray; Silvia Franceschi
Journal:  Lancet Glob Health       Date:  2016-07-25       Impact factor: 26.763

5.  Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance.

Authors:  Uzoma K Iheagwara; Pamela L Beatty; Phu T Van; Ted M Ross; Jonathan S Minden; Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2013-12-05       Impact factor: 11.151

Review 6.  HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.

Authors:  Maura L Gillison; Anil K Chaturvedi; Douglas R Lowy
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

Review 7.  The Commensal Microbiota and Viral Infection: A Comprehensive Review.

Authors:  Na Li; Wen-Tao Ma; Ming Pang; Qin-Lei Fan; Jin-Lian Hua
Journal:  Front Immunol       Date:  2019-07-04       Impact factor: 7.561

8.  The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL.

Authors:  Berk Aykut; Smruti Pushalkar; Ruonan Chen; Qianhao Li; Raquel Abengozar; Jacqueline I Kim; Sorin A Shadaloey; Dongling Wu; Pamela Preiss; Narendra Verma; Yuqi Guo; Anjana Saxena; Mridula Vardhan; Brian Diskin; Wei Wang; Joshua Leinwand; Emma Kurz; Juan A Kochen Rossi; Mautin Hundeyin; Constantinos Zambrinis; Xin Li; Deepak Saxena; George Miller
Journal:  Nature       Date:  2019-10-02       Impact factor: 49.962

9.  Mutational heterogeneity in cancer and the search for new cancer-associated genes.

Authors:  Michael S Lawrence; Petar Stojanov; Paz Polak; Gregory V Kryukov; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Chip Stewart; Craig H Mermel; Steven A Roberts; Adam Kiezun; Peter S Hammerman; Aaron McKenna; Yotam Drier; Lihua Zou; Alex H Ramos; Trevor J Pugh; Nicolas Stransky; Elena Helman; Jaegil Kim; Carrie Sougnez; Lauren Ambrogio; Elizabeth Nickerson; Erica Shefler; Maria L Cortés; Daniel Auclair; Gordon Saksena; Douglas Voet; Michael Noble; Daniel DiCara; Pei Lin; Lee Lichtenstein; David I Heiman; Timothy Fennell; Marcin Imielinski; Bryan Hernandez; Eran Hodis; Sylvan Baca; Austin M Dulak; Jens Lohr; Dan-Avi Landau; Catherine J Wu; Jorge Melendez-Zajgla; Alfredo Hidalgo-Miranda; Amnon Koren; Steven A McCarroll; Jaume Mora; Brian Crompton; Robert Onofrio; Melissa Parkin; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Charles W M Roberts; Jaclyn A Biegel; Kimberly Stegmaier; Adam J Bass; Levi A Garraway; Matthew Meyerson; Todd R Golub; Dmitry A Gordenin; Shamil Sunyaev; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2013-06-16       Impact factor: 49.962

10.  The gut mycobiome: The overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions.

Authors:  Jessica R Galloway-Peña; Dimitrios P Kontoyiannis
Journal:  PLoS Pathog       Date:  2020-04-02       Impact factor: 6.823

View more
  1 in total

Review 1.  Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy.

Authors:  Pei Zhou; Yawen Hu; Xiaoyan Wang; Luxuan Shen; Xinghao Liao; Yajuan Zhu; Jiadong Yu; Fulei Zhao; Yi Zhou; Hengshui Shen; Jiong Li
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.